EVALUATION OF SEVERAL ADJUVANTS AS ALTERNATIVES TO THE USE OF FREUNDS-ADJUVANT IN RABBITS

被引:47
|
作者
LEENAARS, PPAM
HENDRIKSEN, CFM
ANGULO, AF
KOEDAM, MA
CLAASSEN, E
机构
[1] NATL INST PUBL HLTH & ENVIRONM PROTECT,3720 BA BILTHOVEN,NETHERLANDS
[2] DUTCH ORG APPL SCI RES,MED BIOL LAB,2280 HV RIJSWIJK,NETHERLANDS
关键词
D O I
10.1016/0165-2427(94)90022-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In three experiments we evaluated several types of adjuvants as an alternative to Freund's adjuvant (FA). In the first experiment three adjuvant preparations (a water-in-oil emulsion (Specol), a combination preparation of monophosphoryl lipid A + trehalose dimycolate + cell wall skeleton and a non-ionic block polymer surfactant (TiterMax)) were evaluated. The adjuvants were combined with three different types of weak immunogenic antigens (synthetic peptide, glycolipid and particulate antigen) and administered following the intramuscular and subcutaneous route. The evaluation was based on clinical, pathological and immunological parameters. The animals did not appear to be severely or chronically impaired by the experiment. After injection of the RIBI adjuvant, side effects of the same severity as with FA were induced, while low antibody titers were produced. TiterMax caused few side effects, while antibody responses were very low. In comparing Specol and FA, Specol had far fewer adverse effects than FA. However, Specol had immunostimulating properties of the same level as FA. In the second experiment, the effect of injected volume of FA on side effects and antibody titer was studied. Immunization of rabbits with a total of 0.5 mi FA at different sites does not seem to increase the immune response when compared with the immune response seen after injection of 0.5 mi FA at one site. However side effects were seen in all the animals. In the third experiment, the side effects following intradermal (i.d.) injection of the adjuvants were studied. After i.d. injection of FA or RIBI, undesirable effects were found. No side effects occurred after i.d. injection of Specol or TiterMax. From the studies it is concluded that Specol is an alternative to FA for hyperactivation of the immune response in rabbits.
引用
收藏
页码:225 / 241
页数:17
相关论文
共 50 条
  • [1] LEGIONELLA, MYCOBACTERIA, AND FREUNDS-ADJUVANT
    CHERRY, WB
    MCKINNEY, RM
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (22): : 1242 - 1242
  • [2] ACCIDENTAL INJECTION OF FREUNDS-ADJUVANT WITH MINIMAL REACTION
    MORRIS, CA
    EVERALL, PH
    LANCET, 1979, 2 (8139): : 424 - 425
  • [3] AN EVALUATION OF DISTRESS FOLLOWING INTRAPERITONEAL IMMUNIZATION WITH COMPLETE FREUNDS-ADJUVANT IN MICE
    HESSLER, JR
    TOTH, LA
    DUNLAP, A
    OLSON, GA
    LABORATORY ANIMAL SCIENCE, 1988, 38 (04): : 496 - 497
  • [5] ACCIDENTAL INJECTION OF FREUNDS-ADJUVANT WITHOUT SYSTEMIC SEQUELAE
    COCHRAN, AJ
    MCLEAN, R
    LANCET, 1979, 2 (8138): : 356 - 356
  • [6] FREUNDS-ADJUVANT (FA) INDUCED PULMONARY GRANULOMAS IN RABBITS - USE OF INVIVO BRONCHOALVEOLAR LAVAGE (BAL) ANALYSIS AND EFFECT OF CAPTOPRIL (CAP)
    ARANSON, R
    GOLDSTEIN, N
    POLISHER, M
    COWAN, D
    LIPPMANN, M
    KUEPPERS, F
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (04): : A314 - A314
  • [7] OVALBUMIN INJECTED WITH COMPLETE FREUNDS-ADJUVANT STIMULATES CYTOLYTIC RESPONSES
    KE, Y
    LI, Y
    KAPP, JA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) : 549 - 553
  • [8] EXPERIMENTAL CARCINOGENESIS OF THE BLADDER FOLLOWING ADMINISTRATION OF FREUNDS-ADJUVANT AND LEVAMISOLE
    ANICHKOV, NM
    LOMAKINA, II
    ZUBZHITSKII, YN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1980, 89 (06) : 816 - 819
  • [9] THE EFFECT OF AMETHOPTERIN ON THE INFLAMMATORY RESPONSE INDUCED BY THE COMPLETE FREUNDS-ADJUVANT (CFA)
    AMADO, CAB
    ZUBIOLI, A
    ARQUIVOS DE BIOLOGIA E TECNOLOGIA, 1986, 29 (02): : 371 - 382
  • [10] RESPIRATORY EPITHELIAL PERMEABILITY IN COMPLETE FREUNDS-ADJUVANT RAT LUNG GRANULOMATOSIS
    MORDELETDAMBRINE, M
    STANISLASLEGUERN, G
    HENZEL, D
    BARRITAULT, L
    HUCHON, G
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) : 1660 - 1666